San Francisco, 19-20 April 2013

"The Truth of Personalized Medicine: Our Commons Future"

Past Sponsors

The Commons Congress, the Synapse platform and the work of Sage Bionetworks is only possible because of the generous support received from sponsors and supporters.
Sage Bionetworks Supporters


Ewing Marion Kauffman

The Kauffman Foundation is working to further understand the phenomenon of entrepreneurship, to advance entrepreneurship education and training efforts, to promote entrepreneurship-friendly policies, and to better facilitate the commercialization of new technologies by entrepreneurs and others that have great promise for improving the economic welfare of the world.


Google’s mission is to organize the world’s information and make it universally accessible and useful. Since the beginning, we’ve focused on providing the best user experience possible. Whether we’re designing a new Internet browser or a new tweak to the look of the homepage, we take great care to ensure that they will ultimately serve you, rather than our own internal goal or bottom line.



Avon Foundation

The Avon Foundation has been improving and saving women’s lives since it was founded in 1955, and we are proud to be the largest corporate philanthropy dedicated to women’s causes globally.  Today our mission is focused on breast cancer and domestic violence, as well as emergency and disaster relief, touching lives across the country and around the world.


Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website,

Pfizer, Inc.

Working together for a healthier world. At today’s Pfizer, we’re creating connections with those who can inspire us to do more, spark new ideas, and share our challenges and successes.

 Medco Health Solutions

Medco cares for millions of Americans. At Medco, we’re about more than managing prescription benefits. We help people stay healthier. We’re pioneering innovations in personalized medicine, dispensing technology, and patient care that help lower costs and improve lives. For the nearly 60 million people we serve, the Medco Pharmacy is central to delivering on our promise of better health and prescription safety.

Mount Sinai School of Medicine

The Institute for Genomics and Multiscale Biology at the Mount Sinai School of Medicine (MSSM) is working to enable translational systems biology. The Institute faculties are experts in a wide range of areas such as machine learning, biostatistics, genetics, genomics, sequencing technology, data science, and high-performance computing (HPC). They work in collaboration with MSSM’s researchers, clinicians, and institutes on fundamental and applied projects in biology, computation, and medicine. These projects include generating diverse biological data, integrating these data to uncover mechanisms underlying complex human conditions, and the design and implementation of HPC systems to enable the creation, testing and iterative refinement of disease models. At every step, we focus on the ultimate goal of developing novel diagnostics and therapeutics for human disease in collaboration with the medical and research community at Mount Sinai and beyond.


Microsoft is investing in innovative technologies to empower the next level of scientific research and collaboration in the cloud. Our products work to unlock data and information assets, help you store them as an innovative network of concepts and relationships, and promote discovery and transformation of biological insights into clinical understanding. We harness the power of cloud computing for enterprises to solve the problems of big data management and complex analytics and modeling of research data. We help you bring together data and algorithms from disparate systems to share openly or privately—both within your institutions and from partner organizations. Coupled with our other offerings of HealthVault and Amalga, Microsoft is delivering connected health solutions that allow you to address tomorrow’s data challenges and transform the way you do research. Learn more at

Johnson & Johnson

Johnson & Johnson is the world’s most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical and medical devices and diagnostics markets. The more than 250 Johnson & Johnson operating companies employ approximately 115,500 people in 60 countries throughout the world.


CHDI Foundation

CHDI Foundation, Inc. is a privately-funded, not-for-profit, biomedical research organization that is exclusively dedicated to rapidly discovering and developing therapies that slow the progression of Huntington’s disease (HD). As a collaborative enabler, CHDI seeks to bring the right partners together to identify and address critical scientific issues and move drug candidates to clinical evaluation as quickly as possible. Our scientists work closely with a network of more than 600 researchers in academic and industrial laboratories around the world in the pursuit of these novel therapies, providing strategic scientific direction to ensure that our common goals remain in focus.  More information about CHDI can be found at

Recombinant Data

Recombinant offers healthcare providers and academic medical centers proven, leading-edge data warehousing and clinical intelligence solutions to deliver higher quality outcomes, accelerate personalized medicine, and lower costs. Our team of industry veterans is focused on improving the flow of reliable data to power clinical and research applications in a secure, compliant environment.


Novartis provides healthcare solutions that address the evolving needs of patients and societies. The Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization of Novartis. With approximately 6 000 scientists and physicians around the world, research at NIBR is focused on discovering innovative new drugs that can change the practice of medicine. Headquartered in the United States in Cambridge, Massachusetts, the NIBR research network includes a major research center in Basel, Switzerland, and additional centers in East Hanover, New Jersey, USA; Emeryville, California, USA; La Jolla, California, USA; Siena, Italy; Horsham, England; Singapore; and Shanghai, China.


GNS Healthcare

GNS Healthcare is a big data analytics company that has developed a scalable approach for the discovery of what works in healthcare, and for whom. Our analytics solutions are being applied across the healthcare industry: from pharmaceutical and biotechnology companies, health plans and hospitals, to integrated delivery systems, Pharmacy Benefits Managers (PBMs), and Accountable Care Organizations (ACOs). Whether your organization is delivering care or developing personalized therapies and diagnostics, GNS Healthcare can help you discover the knowledge you need to match patients with treatments that work.

H3 Biomedicine

H3 Biomedicine Inc. is a privately held, uniquely structured oncology discovery enterprise. At H3, we seek to become a prolific source of new drugs that treat more human cancers with greater success. H3 Biomedicine is applying the expertise of leading scientists to the integration of insights from cancer genomics with innovative capabilities in synthetic chemistry and tumor biology to pursue patient-based, genomics-driven, small molecule drugs, which represent the most promising current opportunity in cancer therapeutics.

IBM Computational Biology Center

We pursue basic and exploratory research at the interface of information technology and biology. Information technology plays a vital role in enabling new science and discovery in biology. Advances in high throughput and platform technologies in biology present an unprecedented challenge in scale, management, and analysis of biological data. Advances in computing architecture and scale are enabling simulations of complex biological processes at various organizational levels from atomic to cellular and beyond.


NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data.


Sage Bionetworks also wishes to thank the organizations who provide ongoing support and funding and help make the Commons Congress possible.
Sage Bionetworks Supporters

Comments are closed.